Pricing Log in Create free account

Kyverna Therapeutics, Inc. (KYTX) vs Scribe Therapeutics Inc. (SCTX)

Kyverna Therapeutics, Inc. and Scribe Therapeutics Inc. are both Biotechnology companies. Kyverna Therapeutics, Inc. and Scribe Therapeutics Inc. are of similar size ($293.1M and $285.1M). Across the 4 metrics below, Scribe Therapeutics Inc. leads on 3 and Kyverna Therapeutics, Inc. on 1.

Valuation

Metric KYTX SCTX Biotechnology median
P/E n/m — 10.60
P/S n/m n/m 9.40
P/B 1.78 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (60.62%) — (32.88%)
Free cash flow yield (53.83%) 0.00% (23.13%)

Profitability

Metric KYTX SCTX Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (87.24%) — (51.96%)
Return on assets (68.40%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYTX SCTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (9.31%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric KYTX SCTX Biotechnology median
Debt to equity 0.15 0.00 0.00
Current ratio 9.06 0.57 4.97
Net debt to EBITDA 1.51 0.00 1.01

Dividend

Metric KYTX SCTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KYTX SCTX Biotechnology median
Market cap 285.10m 293.06m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack